Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.
Trump threatened "very high" tariffs on Denmark amid Greenland dispute, raising fears of higher prices for Danish ...
The cost to taxpayers could be enormous.Sales growth of Zepbound in the U.S. has been constrained by rules that bar Medicare, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback